Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction - A 13-year nationwide cohort study.
Victor Chien-Chia WuShao-Wei ChenAn-Hsun ChouPei-Chi TingChih-Hsiang ChangMichael WuMing-Jer HsiehChao-Yung WangShang-Hung ChangMing-Shyan LinKuo-Chun HungI-Chang HsiehPao-Hsien ChuCheng-Shyong WuYu-Sheng LinPublished in: PloS one (2019)
In cirrhotic patients with AMI, DAPT offers benefit with decreased recurrent MI at the expense of increased gastrointestinal bleeding.